Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg – Glumight MV1

Werke Health has introduced Gulmight MV1 (Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg) for diabetes management. At Werke Health, this tablet is introduced as part of our ethical range, reflecting top-notch quality and manufacturing by leading pharmaceutical firms. Werke Health provides Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg in safe packs for better protection.

Uses

Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg tablets is used in the treatment of type 2 diabetes mellitus. This combination helps control blood sugar by reducing sugar production in the liver, increasing the effect of insulin, and delaying glucose absorption from the intestine. With regular use, this medicine provides patients with better sugar control and long-term diabetes management, thereby reducing the risk of diabetes related complications.

Dosage

. The dosage of Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg tablets is decided according to doctor’s advice, depending on the patient’s blood sugar level and health condition.
. Normally, this medicine is taken with meals or immediately before meals so that sugar absorption remains under control and the stomach is not upset.
. Dose should not be skipped or doubled.
. It is always important to follow your doctor’s guidance for best results.

Precautions

. Before taking Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg, the patient must follow some precautions.
. If you have kidney, liver or heart problems, inform the doctor first.
. It is important to regularly monitor your sugar levels before taking this medicine.
. Avoid alcohol as it can lower blood sugar too much.
. If you are pregnant or breastfeeding, do not take this medicine without the doctor’s advice.

How does Gulmight-MV1 Tablets work?

Gulmight-MV1 Tablets (Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg) is a combination of three powerful medicines which help to control diabetes.

. Glimepiride increases the release of insulin by stimulating the pancreas, which allows the sugar to reach the cells in the body more easily.
. Metformin reduces extra sugar production in the liver and improves insulin sensitivity.
. Voglibose slows down the breakdown of carbohydrates in food, so that there is no sudden high in blood sugar levels after meals.

The combined action of these three effectively controls blood sugar and helps in long-term diabetes management.

Side Effects

Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg Tablets are generally well tolerated, but some patients may develop minor side effects. Common side effects include:

. Nausea
. Vomiting
. Stomach pain
. Gas
. Diarrhea

Occasionally patients may experience hypoglycemia (low sugar), sweating, dizziness, or weakness, especially if food is skipped. In rare cases problems such as liver function changes or skin allergy may also occur. If side effects are very severe or persist continuously, contact your doctor immediately.

Storage

. Keep Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg Tablets at room temperature (around 25°C) and store away from direct sunlight, moisture and heat.
. There is no need to keep it in the refrigerator unless the doctor specifically says so.
. Always keep the tablets in the original blister pack to ensure their quality is safe.
. It is very important to keep them away from the reach of children.
. Keep checking the expiry date and never use expired medicine.

Drug Interactions

The effect of these tablets may change when taken with other medicines. If used along with drugs that lower blood sugar, such as insulin or other sulfonylureas, the risk of hypoglycemia (low blood sugar) can increase. Always inform your doctor about any medicines you are taking to avoid harmful interactions. Blood pressure medicines (beta blockers, ACE inhibitors) can also affect the sugar level. Interactions are possible with medicines like pain killers (NSAIDs), steroids, thyroid medicines, diuretics and some antibiotics. Therefore the patient should always tell his doctor which other medicines or supplements he is taking.

Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg by Werke Health

Backed by doctors’ trust, Werke Health’s Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg is a reliable choice for diabetes care. These tablets witness consistent demand throughout the year, making them a profitable option for pharma businesses.

With its roots in Panchkula, Haryana, and a strong presence in Mumbai, Werke Health stands as a dependable partner in the pharma industry. This wide reach helps us deliver medicines quickly and provide smooth support anywhere in India.

Pharma distributors and PCD companies looking for Gulmight-MV1 may connect with Werke Health for supply and support.

contact us
Name: Werke Health
Phone: +91-6284236516
Email: werkehealth@gmail.com